Purdue Pharma begins several days of hearings Wednesday to finalize a $7.4 billion bankruptcy restricting plan that no longer ...
The company and the once-prominent family behind the drug OxyContin agreed Thursday to increase their financial contribution to resolve mass opioid litigation. The Sacklers and Purdue Pharma ...
The Sackler family, owners of OxyContin maker Purdue Pharma, has agreed to pay $6 billion to settle long-running litigation alleging they fueled the nation’s opioid epidemic, The New York Times ...
This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. The attorneys general for eight holdout ...